Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment

被引:40
作者
Marella, M
Gaggioli, C
Batoz, M
Deckert, M
Tartare-Deckert, S
Chabry, J
机构
[1] CNRS, Inst Pharmacol Mol & Cellulaire, Unite Mixte Rech 6097, F-06560 Valbonne, France
[2] Fac Med, INSERM, U597, F-06107 Nice 02, France
[3] Hop Archet, INSERM, U576, F-06202 Nice 03, France
关键词
D O I
10.1074/jbc.M410966200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transmissible spongiform encephalopathies are accompanied by the recruitment of microglial cells in the vicinity of amyloid aggregates of the pathological prion protein (PrPres). We previously showed that PrPres itself triggered the recruitment of microglia by interacting with neurons leading to the up-regulation of the expression level of chemokines, mainly RANTES (regulated on activation normal T cell expressed and secreted). The intracellular mechanisms underlying the PrPres-inducible expression of chemokines in this setting are not clear. Here we demonstrate that the mitogen-activated protein kinase pathway is switched on shortly after PrPres exposure to neurons leading to the expression of early growth response factor-1 (Egr-1), a transcription factor initially linked to differentiation and growth and to up-regulation of RANTES mRNA expression. PD98059, a selective inhibitor of extracellular signal-regulated kinase1/2 activation, resulted in a decrease of RANTES mRNA expression and as a consequence to the lowering of microglial cell migration. Neuronal overexpression of Nab2, a corepressor of Egr-1, produced similar effects. PrPres-induced chemoattraction is independent of the presence of PrPc and the laminin receptor on the neuronal cell surface. Our report is the first demonstration that PrPres exposure on neurons results in the activation of the MAP kinase signaling pathway that acts as a master switch to trigger neuronal expression of regulators of chemoattraction.
引用
收藏
页码:1529 / 1534
页数:6
相关论文
共 46 条
[1]   MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia [J].
Alessandrini, A ;
Namura, S ;
Moskowitz, MA ;
Bonventre, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12866-12869
[2]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[3]   Human chemokines: An update [J].
Baggiolini, M ;
Dewald, B ;
Moser, B .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :675-705
[4]   Mutation in the phosphorylation sites of MAP kinase blocks learning-related internalization of apCAM in Aplysia sensory neurons [J].
Bailey, CH ;
Kaang, BK ;
Chen, M ;
Martin, KC ;
Lim, CS ;
Casadio, A ;
Kandel, ER .
NEURON, 1997, 18 (06) :913-924
[5]   Microglial activation varies in different models of Creutzfeldt-Jakob disease [J].
Baker, CA ;
Lu, ZY ;
Zaitsev, I ;
Manuelidis, L .
JOURNAL OF VIROLOGY, 1999, 73 (06) :5089-5097
[6]   Unique inflammatory RNA profiles of microglia in Creutzfeldt-Jakob disease [J].
Baker, CA ;
Manuelidis, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (02) :675-679
[7]   Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles [J].
Baker, CA ;
Martin, D ;
Manuelidis, L .
JOURNAL OF VIROLOGY, 2002, 76 (21) :10905-10913
[8]  
Brown DR, 1997, HISTOL HISTOPATHOL, V12, P883
[9]   Microglia and Prion disease [J].
Brown, DR .
MICROSCOPY RESEARCH AND TECHNIQUE, 2001, 54 (02) :71-80
[10]   Nitric oxide and its role in apoptosis [J].
Brüne, B ;
von Knethen, A ;
Sandau, KB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 351 (03) :261-272